|
|
||||||||||
Ambulatory Care Clinical Pharmacy Specialist, Department of Veterans Affairs Medical Center, Iowa City, IA
Assistant Professor (Clinical), Division of Clinical and Administrative Pharmacy, College of Pharmacy; Department of Family Medicine, College of Medicine, The University of Iowa, Iowa City
Reprints: Michael E Ernst PharmD BCPS, Division of Clinical and Administrative Pharmacy, College of Pharmacy, 01287 PFP, 200 Hawkins Dr., Iowa City, IA 52242-1097, fax 319/384-8515, michael-ernst{at}uiowa.edu
OBJECTIVE: To review the literature evaluating the use of selective serotonin-reuptake inhibitors (SSRIs) for the treatment of hot flashes.
DATA SOURCES: Biomedical literature was accessed through MEDLINE (1966June 2003), MD Consult, and references of reviewed articles. Key search terms used were hot flashes, vasomotor symptoms, antidepressants, and SSRIs.
DATA SYNTHESIS: Recent evidence from the Women's Health Initiative precludes the use of traditional hormonal therapy in some women. Nonhormonal therapies are possible options, but conflicting evidence of efficacy exists.
CONCLUSIONS: Although further studies are warranted, preliminary data suggest that SSRIs are generally modestly successful in reducing the frequency and severity of hot flashes.
Key Words: antidepressants, hot flashes, selective serotonin-reuptake inhibitors
Published Online, June 8, 2004. www.theannals.com, DOI 10.1345/aph.1D512